Call for Proposals: FP7-HEALTH-2012-INNOVATION-2

This call is dedicated to a specific SME innovation initiative designed to encourage stronger SME efforts towards research and innovation. SMEs need to have a leading or coordinating role in the consortium and 50 % of EU funding requested going to SMEs or SMEs joint venture. Expected project results should be of clear interest and potential benefit to SME(s).

Call identifier: FP7-HEALTH-2012-INNOVATION-2

Proposal submission and evaluation: two-stage procedure.

Deadline for stage 1 proposals: 27 September 2011

Topics called:
1. BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH
1.4 INNOVATIVE THERAPEUTIC APPROACHES AND INTERVENTIONS
2. TRANSLATING RESEARCH FOR HUMAN HEALTH
2.3. TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH
2.3.0 CROSS-CUTTING
2.4. TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES
2.4.5 OTHER CHRONIC DISEASES

For further information and key documents required for proposal preparation, please visit:
http://ec.europa.eu/research/participants/portal/page/cooperation?callIdentifier=FP7-HEALTH-2012-INNOVATION-2

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...